2022
Resolving icteric interference by a novel photoisomerization device: Bilibox
Vera MA, Koch CD, El-Khoury JM. Resolving icteric interference by a novel photoisomerization device: Bilibox. Clinical Biochemistry 2022, 115: 112-115. PMID: 35882276, DOI: 10.1016/j.clinbiochem.2022.07.004.Peer-Reviewed Original ResearchConceptsDirect bilirubinIcteric interferenceAforementioned analytesChemical reactivityPhotoisomerizationRoutine laboratory testingEndogenous interferencesBilirubin elevationBaseline creatinineAssay reagentsLaboratory testingDilutional methodMin of treatmentCreatinineEnzymatic creatinine assayIcterusBilirubinChemistry testingClinical samplesCreatinine assaysHeparin vacutainersTreatmentAnalytesIctericRepeat measurements
2021
Longitudinal Assessment of SARS-CoV-2 Anti-Nucleocapsid and anti-Spike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection
El-Khoury JM, Schulz WL, Durant TJS. Longitudinal Assessment of SARS-CoV-2 Anti-Nucleocapsid and anti-Spike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection. The Journal Of Applied Laboratory Medicine 2021, 6: jfab030-. PMID: 33822964, PMCID: PMC8083453, DOI: 10.1093/jalm/jfab030.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionDays post-PCR positivitySARS-CoV-2-positive cohortRBD antibodiesAnti-SARSSerologic assaysSARS-CoV-2 serologic assaysDiagnostic sensitivityElecsys Anti-SARSCoV-2 SResidual clinical samplesAntibody testingRemote historyCoV-2S1-RBDUS populationLongitudinal assessmentInfection statusInfectionDiagnostic aidCohortTime pointsDiscrepant resultsClinical samplesPositivity